These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 18028412)

  • 1. Molecular background of EPM1-Unverricht-Lundborg disease.
    Joensuu T; Lehesjoki AE; Kopra O
    Epilepsia; 2008 Apr; 49(4):557-63. PubMed ID: 18028412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cystatin B: mutation detection, alternative splicing and expression in progressive myclonus epilepsy of Unverricht-Lundborg type (EPM1) patients.
    Joensuu T; Kuronen M; Alakurtti K; Tegelberg S; Hakala P; Aalto A; Huopaniemi L; Aula N; Michellucci R; Eriksson K; Lehesjoki AE
    Eur J Hum Genet; 2007 Feb; 15(2):185-93. PubMed ID: 17003839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered tryptophan metabolism in the brain of cystatin B-deficient mice: a model system for progressive myoclonus epilepsy.
    Vaarmann A; Kaasik A; Zharkovsky A
    Epilepsia; 2006 Oct; 47(10):1650-4. PubMed ID: 17054687
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of lysosomal association of cystatin B proteins representing progressive myoclonus epilepsy, EPM1, mutations.
    Alakurtti K; Weber E; Rinne R; Theil G; de Haan GJ; Lindhout D; Salmikangas P; Saukko P; Lahtinen U; Lehesjoki AE
    Eur J Hum Genet; 2005 Feb; 13(2):208-15. PubMed ID: 15483648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical picture of EPM1-Unverricht-Lundborg disease.
    Kälviäinen R; Khyuppenen J; Koskenkorva P; Eriksson K; Vanninen R; Mervaala E
    Epilepsia; 2008 Apr; 49(4):549-56. PubMed ID: 18325013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein aggregation as a possible cause for pathology in a subset of familial Unverricht-Lundborg disease.
    Ceru S; Rabzelj S; Kopitar-Jerala N; Turk V; Zerovnik E
    Med Hypotheses; 2005; 64(5):955-9. PubMed ID: 15780491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pathogenetic hypothesis of Unverricht-Lundborg disease onset and progression.
    Franceschetti S; Sancini G; Buzzi A; Zucchini S; Paradiso B; Magnaghi G; Frassoni C; Chikhladze M; Avanzini G; Simonato M
    Neurobiol Dis; 2007 Mar; 25(3):675-85. PubMed ID: 17188503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [From gene to disease; progressive myoclonus epilepsy of Unverricht-Lundborg and mutations in the cystatin B gene].
    de Haan GJ; Halley DJ; Deelen WH; Lindhout D
    Ned Tijdschr Geneeskd; 2002 May; 146(18):846-8. PubMed ID: 12038222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice.
    Pennacchio LA; Bouley DM; Higgins KM; Scott MP; Noebels JL; Myers RM
    Nat Genet; 1998 Nov; 20(3):251-8. PubMed ID: 9806543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seizures, ataxia, and neuronal loss in cystatin B heterozygous mice.
    Kaasik A; Kuum M; Aonurm A; Kalda A; Vaarmann A; Zharkovsky A
    Epilepsia; 2007 Apr; 48(4):752-7. PubMed ID: 17319918
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular background of progressive myoclonus epilepsy.
    Lehesjoki AE
    EMBO J; 2003 Jul; 22(14):3473-8. PubMed ID: 12853462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unverricht-Lundborg progressive myoclonus epilepsy in Oman.
    Santoshkumar B; Turnbull J; Minassian BA
    Pediatr Neurol; 2008 Apr; 38(4):252-5. PubMed ID: 18358403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA deamination enables direct PCR amplification of the cystatin B (CSTB) gene-associated dodecamer repeat expansion in myoclonus epilepsy type Unverricht-Lundborg.
    Weinhaeusel A; Morris MA; Antonarakis SE; Haas OA
    Hum Mutat; 2003 Nov; 22(5):404-8. PubMed ID: 14517952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severer phenotype in Unverricht-Lundborg disease (EPM1) patients compound heterozygous for the dodecamer repeat expansion and the c.202C>T mutation in the CSTB gene.
    Koskenkorva P; Hyppönen J; Aikiä M; Mervaala E; Kiviranta T; Eriksson K; Lehesjoki AE; Vanninen R; Kälviäinen R
    Neurodegener Dis; 2011; 8(6):515-22. PubMed ID: 21757863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early microglial activation precedes neuronal loss in the brain of the Cstb-/- mouse model of progressive myoclonus epilepsy, EPM1.
    Tegelberg S; Kopra O; Joensuu T; Cooper JD; Lehesjoki AE
    J Neuropathol Exp Neurol; 2012 Jan; 71(1):40-53. PubMed ID: 22157618
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dodecamer repeat expansion in cystatin B gene in progressive myoclonus epilepsy.
    Lalioti MD; Scott HS; Buresi C; Rossier C; Bottani A; Morris MA; Malafosse A; Antonarakis SE
    Nature; 1997 Apr; 386(6627):847-51. PubMed ID: 9126745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical features and genetics of Unverricht-Lundborg disease.
    Lehesjoki AE
    Adv Neurol; 2002; 89():193-7. PubMed ID: 11968445
    [No Abstract]   [Full Text] [Related]  

  • 18. Unstable insertion in the 5' flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1.
    Lafrenière RG; Rochefort DL; Chrétien N; Rommens JM; Cochius JI; Kälviäinen R; Nousiainen U; Patry G; Farrell K; Söderfeldt B; Federico A; Hale BR; Cossio OH; Sørensen T; Pouliot MA; Kmiec T; Uldall P; Janszky J; Pranzatelli MR; Andermann F; Andermann E; Rouleau GA
    Nat Genet; 1997 Mar; 15(3):298-302. PubMed ID: 9054946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unverricht-Lundborg disease.
    Crespel A; Ferlazzo E; Franceschetti S; Genton P; Gouider R; Kälviäinen R; Korja M; Lehtinen MK; Mervaala E; Simonato M; Vaarmann A
    Epileptic Disord; 2016 Sep; 18(S2):28-37. PubMed ID: 27582036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal microglial activation in the Cstb(-/-) mouse, a model for progressive myoclonus epilepsy, EPM1.
    Okuneva O; Körber I; Li Z; Tian L; Joensuu T; Kopra O; Lehesjoki AE
    Glia; 2015 Mar; 63(3):400-11. PubMed ID: 25327891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.